Browsing Tag
Sirtex Medical
2 posts
Sirtex secures expanded CE Mark approval for SIR-Spheres Y-90 resin microspheres in Europe, widening access to liver cancer treatment
Sirtex secures CE Mark expansion for SIR-Spheres Y-90 in Europe, unlocking wider access to liver cancer patients and reinforcing its oncology leadership.
Sirtex Medical earns FDA nod for SIR-Spheres® Y-90 in treating unresectable liver cancer in U.S.
Sirtex Medical gains FDA approval for SIR-Spheres® Y-90 in treating unresectable hepatocellular carcinoma, expanding its U.S. radioembolization therapy scope.